Groupe de Recherche sur les formes Injectables et les Technologies Associées
- Research works
- 35 ▲ 136% vs 2013–17
- Citations
- 779 22.1 per fractional work
- Top-10% rate
- 17.6% record average 16.5%
- Open access
- 54% world 28%
Not ranked overall: Groupe de Recherche sur les formes Injectables et les Technologies Associées is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 11.2×. Every wedge is a field page.
- Veterinary 11.2×
- Health Professions 6.8×
- Pharmacology, Toxicology and Pharmaceutics 4.9×
- Medicine 3.0×
- Nursing 2.6×
- Chemistry 1.9×
- Immunology and Microbiology 1.6×
- Mathematics 1.0×
- Chemical Engineering 0.8×
- Materials Science 0.6×
- Neuroscience 0.5×
- Economics, Econometrics and Finance 0.5×
- Biochemistry, Genetics and Molecular Biology 0.4×
- Engineering 0.3×
- Environmental Science 0.2×
- Psychology 0.2×
- Agricultural and Biological Sciences 0.1×
- Business, Management and Accounting 0.1×
- Computer Science 0.0×
Which keywords describe research at Groupe de Recherche sur les formes Injectables et les Technologies Associées?
By fractional works in all years, weighted toward what it does more of than the world: Antineoplastic Drugs, Occupational Exposure, Lymphoma, Rituximab, Continuous Infusion, PET Imaging, Clinical Trials and Classification.
- Pharmacokinetics
- Prognostic Factors
- Inappropriate Medication Use
- Pediatric Pharmacokinetics
- Off-Label Drug Use
- Elderly
- Adverse Events
- Infusion Systems
- Drug Development
- Molecular Profiling
- Healthcare Management
- Classification
- Clinical Trials
- Epidemiology
- Rituximab
- Occupational Exposure
- Antineoplastic Drugs
- Lymphoma
- Continuous Infusion
- PET Imaging
- Machine Learning
- Drug Delivery
- Medication Adherence
- Adverse Drug Reactions
- Medication Errors
- Syringe Pumps
- Chemotherapy
- Medical Errors
- Patient Safety Culture
- Critical Care
- Polypharmacy
- Antimicrobial Resistance
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 32 words, with their numbers
- Antineoplastic Drugs3▲ 1317×1 topic
- Occupational Exposure3▲ 115×1 topic
- Lymphoma2▲ 48×3 topics
- Rituximab2▲ 42×2 topics
- Continuous Infusion2▲ 124×2 topics
- Epidemiology2▲ 1.39×19 topics
- PET Imaging2▲ 25×4 topics
- Clinical Trials2▲ 8.1×8 topics
- Machine Learning2▲ 2.4×4 topics
- Classification2▲ 14×1 topic
- Drug Delivery2▲ 9.9×5 topics
- Healthcare Management2▲ 76×2 topics
- Medication Adherence2▲ 82×2 topics
- Molecular Profiling2▲ 42×1 topic
- Adverse Drug Reactions2▲ 71×3 topics
- Drug Development2▲ 32×3 topics
- Medication Errors2▲ 91×2 topics
- Infusion Systems2▲ 767×1 topic
- Syringe Pumps2▲ 767×1 topic
- Adverse Events1▲ 60×2 topics
- Chemotherapy1▲ 5.5×14 topics
- Elderly1▲ 16×2 topics
- Medical Errors1▲ 109×1 topic
- Off-Label Drug Use1▲ 110×1 topic
- Patient Safety Culture1▲ 174×1 topic
- Pediatric Pharmacokinetics1▲ 110×1 topic
- Critical Care1▲ 16×5 topics
- Inappropriate Medication Use1▲ 93×1 topic
- Polypharmacy1▲ 93×1 topic
- Prognostic Factors1▲ 7.1×8 topics
- Antimicrobial Resistance1▲ 11×3 topics
- Pharmacokinetics1▲ 10×4 topics
Which research topics does Groupe de Recherche sur les formes Injectables et les Technologies Associées publish most on?
By volume in 2022–2025: Safe Handling of Antineoplastic Drugs, Pharmaceutical Practices and Patient Outcomes, Pharmaceutical studies and practices and Lymphoma Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Safe Handling of Antineoplastic Drugs Occupational Therapy 1 works
- 2 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 1 works
- 3 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works
- 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
- 5 CAR-T cell therapy research Oncology 0 works
- 6 Anesthesia and Sedative Agents Anesthesiology and Pain Medicine 0 works
- 7 Intravenous Infusion Technology and Safety Biomedical Engineering 0 works
- 8 Patient Safety and Medication Errors Emergency Medical Services 0 works
- 9 Electronic Health Records Systems Health Information Management 0 works
- 10 Colorectal Cancer Treatments and Studies Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Groupe de Recherche sur les formes Injectables et les Technologies Associées's research output changed?
Output in 2018–2022 was 136% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lille
- Evaluation des technologies de santé et des pratiques médicales
- Centre de Recherche Droits et Perspectives du droit
- Lille Neurosciences & Cognition
- Lille University Management
- Institute for Translational Research in Inflammation
- IMPact de l'Environnement Chimique sur la Santé humaine
- Sciences Po Lille
- Systèmes avancés de délivrance de principes actifs
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.